Skip to content
OpenCapital
Get started

Context Therapeutics Inc. CNTX Q2 2025 earnings

Reported August 6, 2025 · Before market open

EPS-$0.09Miss by $0.03
EPS estimate-$0.06

Next report

Aug 5, 2026 (In 1 week)
EPS estimate-$0.10

Versus estimates

Diluted EPS

Q1 2026-$0.09Beat by $0.03Q4 2025-$0.14Miss by $0.03Q3 2025-$0.10Miss by $0.01
Q2 2025-$0.09Miss by $0.03
Q1 2025-$0.05In lineQ4 2024-$0.04Beat by $0.01

Ask the moment Context Therapeutics Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Context Therapeutics Inc. report Q2 2025 earnings?
Context Therapeutics Inc. (CNTX) reported Q2 2025 earnings on August 6, 2025 before market open.
What were Context Therapeutics Inc.'s Q2 2025 revenue and EPS?
Context Therapeutics Inc. reported eps of $-0.09 for Q2 2025.
Did Context Therapeutics Inc. beat estimates in Q2 2025?
EPS missed the consensus estimate of $-0.06 by $0.03.
How did Context Therapeutics Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 125.0% from $-0.04.
Where can I find Context Therapeutics Inc.'s Q2 2025 SEC filings?
You can read the 10-Q periodic report (0001842952-25-000081) directly on SEC EDGAR. The filing index links above go to sec.gov.